"Clinical Trials Matchup"

There are many different stem cell clinical trials involving adult stem cells that are leading to life-saving results, and offering new alternatives to surgeries and drugs. With stem cell clinical trials, a cellular approach is used, which in many different studies has appeared to benefit patients in many new ways that were not available before. There are stringent minimum monitoring requirements in clinical trials studies to ensure patient safety, as well, so participants and researchers can feel secure about what they are doing.

Adult stem cell clinical trials do not involve embryonic stem cells that result in the destruction of an embryo; they involve adult stem cells that come from the patient’s own blood or bone marrow, or someone else’s. The transplant appears to be safe, and minimum monitoring requirements in clinical trials studies are in place to make sure of it. Many of these stem cell clinical trials have involved various cancers and multiple sclerosis. Stem cell clinical trials for liver disease have also recently started, and trials for cerebrovascular disease and spinal cord injuries are being considered.

Why monitor clinical trials involving adult stem cells so closely when the patients are using their own stem cells and not those of an embryo? Well, it is still vitally important to be sure that standard practices are followed so the results of the research are likely to be replicated in other patients if the treatment is introduced to the public. Stem cell clinical trials are still very new, and research must be monitored to ensure the safety for patients and the accuracy of results. With minimum monitoring requirements in clinical trials studies, patients and their families can be assured that the research will be as safe as possible. This is vitally important in the continuing support for this type of research, which has already been shown to save lives.

Once clinical trials get under way, there are many steps that must be taken to ensure that they are in accordance with the requirements of the United States Food and Drug Administration. It is important to ensure that clinical research trials are as safe and thorough as possible, not only so that the patients who participate are taken care of, but also to be sure that the results are accurate. After collecting a great deal of information from clinical trials healthy volunteers over an extended period of time, such as vital signs, amount of the drug in their blood and whether their health gets better, the data is ready.

The data collected in clinical trials is sent to the study’s sponsor after the research is complete, at which point it is analyzed using a series of statistical tests that have been proven with time. Clinical research trials have a standard set of procedures, but the goals of these trials are not always the same. Clinical trials might be designed to assess the safety and effectiveness of a new medication or device on a specific kind of patient, or assess the safety and effectiveness of a different dose of a medication than is commonly used. Clinical research trials might also assess the safety and effectiveness of an already marketed medication or device for a new indication, or assess whether the new medication or device is more effective for the patient’s condition than the already used, standard medication or device.

In some cases, clinical trials are also used to compare the effectiveness in patients with a specific disease of two or more already approved or common interventions for that disease. Some clinical research trials even compare three or four medications, doses of medications, or devices against each other. In any case, the clinical trials healthy volunteers will be well aware of what the research trial will entail before they agree to participate.

Most people in the scientific community understand the importance of stem cell clinical trials, and the public is becoming more aware of the benefits since the positive results of these clinical trials are being publicized and understood to great detail. With the minimum monitoring requirements in clinical trials studies, people can be assured that these clinical trials are safe. Why monitor clinical research trials? With a controversial issue such as stem cells, it is vital that the research is monitored.

Now that reporters have had a chance to look at stem cell clinical trials over the last decade that involve adult stem cells, it has become apparent patients with many different diseases and types of heart problems are benefiting. Stem cell clinical trials have led to adult stem cell therapy, which has become a standard of care for treating several types of cancer. There has even been a patient diagnosed with multiple sclerosis, Barry Goudy, who says that his symptoms are gone thanks to the therapy that he received after he signed up for a clinical trial in 2003. And with minimum clinical requirements in clinical trials studies patients like this can feel safe about going into such a trial.

Why monitor clinical trials when they are proving to be effective and people could benefit from immediate release of the treatment on the market? Well, researchers in the scientific community know why monitoring studies, especially when they involve controversial treatments, is important. Stem cell clinical trials, such as Mr. Goudy’s trial that involved the use of his own stem cells, must be monitored to ensure that protocols are followed. This way we know that stem cell clinical trials can lead to proven results that can be trusted in the medical community for years to come, and the public can be more trusting of the results of clinical research investigations.

During stem cell clinical trials, there must be a sponsor to fund the lengthy and expensive research that is required for the effectiveness of the study. There are also stringent minimum monitoring requirements in clinical trials studies of this nature, which ensure the safety of the study and also make sure that they are within the letter of the law. Why monitor clinical trials you ask? Well, after reading further it should be clear to see why the standardized practices of monitoring are so important.

There are a variety of organizations that may sponsor stem cell clinical trials or any other type of clinical trials, including physicians, medical institutions, foundations, voluntary groups, and pharmaceutical companies. There are also federal agencies that sponsor stem cell clinical trials such as the National Institutes of Health. These agencies find the minimum monitoring requirements in clinical trials studies very important, because they do not want to be involved with a study gone wrong. Stem cell clinical trials can take place in a variety of locations and involve many different people who all want to ensure that the investigation is effective.

In addition to the minimum monitoring requirements in clinical research trials, there is also a study plan on which all clinical trials are based, which is known as a protocol. The study plan for stem cell clinical trials is carefully designed to safeguard the health of the participants, as well as answer specific research questions. With such a delicate subject as stem cells, it is easy to see why such a protocol should be followed.

Why monitor clinical trials? Well, it would be foolish not to have a monitoring system in place for such complex research that can affect the future of the medical; it is an important thing to do for the effectiveness of the trial research. And with a new subject area like stem cells, researchers want their trials to be monitored as closely as possible so their results are proven effective.